Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.7213
+0.0003 (0.04%)
At close: Dec 5, 2025, 4:00 PM EST
0.7201
-0.0012 (-0.17%)
After-hours: Dec 5, 2025, 4:10 PM EST
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $29.45 million as of December 5, 2025. Its market cap has decreased by -12.54% in one year.
Market Cap
29.45M
Enterprise Value
-33.25M
1-Year Change
-12.54%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $29.45M, a decrease of -94.91%. That is a compound annual growth rate of -47.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 29.44M | -39.42% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |